{"blog": [], "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Monsanto Company", "name": "organizations", "rank": "2", "is_major": "N"}, {"value": "Bayer AG", "name": "organizations", "rank": "3", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/05/13/business/dealbook/a-bayer-monsanto-tie-up-could-be-a-bitter-pill.html", "document_type": "article", "byline": {"person": [{"lastname": "STORBECK", "firstname": "Olaf", "role": "reported", "organization": "", "rank": 1}, {"lastname": "ALLISON", "firstname": "Kevin", "role": "reported", "organization": "", "rank": 2}], "original": "By OLAF STORBECK and KEVIN ALLISON"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "392", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "Amid reports of an offer, analysts look at the numbers to determine how a deal would work.", "pub_date": "2016-05-13T00:00:00Z", "news_desk": "Business", "headline": {"kicker": "Breakingviews", "main": "A Bayer-Monsanto Tie-Up Could Be a Bitter Pill", "content_kicker": "Breakingviews"}, "print_page": null, "snippet": "Amid reports of an offer, analysts look at the numbers to determine how a deal would work.", "_id": "5734d07b38f0d878c2872d7a", "slideshow_credits": null, "abstract": null}